Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma

被引:0
作者
Schwefel, Georg [1 ]
Bratke, Kai [1 ]
Marchewski, Hannes [1 ]
Virchow, Johann Christian [1 ]
Lommatzsch, Marek [1 ]
机构
[1] Univ Rostock, Rostock, Germany
关键词
Asthma; Immunology; Severe asthma;
D O I
10.1183/13993003.congress-2019.OA3801
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OA3801
引用
收藏
页数:2
相关论文
共 33 条
[1]   Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma [J].
Marchewski, Hannes ;
Bratke, Kai ;
Schwefel, Georg ;
Virchow, Johann Christian ;
Lommatzsch, Marek .
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[2]   Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD [J].
Stoll, Paul ;
Baehker, Anne ;
Ulrich, Martin ;
Bratke, Kai ;
Garbe, Katharina ;
Virchow, J. Christian ;
Lommatzsch, Marek .
EUROPEAN RESPIRATORY JOURNAL, 2015, 46
[3]   The dendritic cell high-affinity IgE receptor is overexpressed in both asthma and severe COPD [J].
Stoll, P. ;
Baehker, A. ;
Ulrich, M. ;
Bratke, K. ;
Garbe, K. ;
Virchow, J. Christian ;
Lommatzsch, M. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2016, 46 (04) :575-583
[4]   Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma [J].
Noorduyn, Stephen G. ;
Lancaster, Brett ;
Gendron, Alain ;
Mbuagbaw, Lawrence ;
Penz, Erika .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[5]   Expression of the high-affinity IgE receptor on peripheral blood dendritic cells: Differential binding of IgE in atopic asthma [J].
Holloway, JA ;
Holgate, ST ;
Semper, AE .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (06) :1009-1018
[6]   Late Breaking Abstract - BENRALIZUMAB IN SEVERE ASTHMA: PRELIMINARY RESULTS FROM THE ITALIAN ANANKE STUDY [J].
D'Amato, Maria ;
Bracciale, Pierluigi ;
Altieri, Elena ;
Caiaffa, Maria Filomena ;
De Michele, Fausto ;
Romagnoli, Micaela ;
Ansaldo, Elena ;
Canonica, Giorgio Walter ;
Pelaia, Girolamo .
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[7]   LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial [J].
FitzGerald, J. Mark ;
Bleecker, Eugene ;
Nair, Parameswaran ;
Korn, Stephanie ;
Ohta, Ken ;
Lommatzsch, Marek ;
Ferguson, Gary ;
Busse, William ;
Barker, Peter ;
Sproule, Stephanie ;
Gilmartin, Geoffrey ;
Werkstrom, Viktoria ;
Aurivillius, Magnus ;
Goldman, Mitchell .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48
[8]   Expression of High-Affinity IgE Receptor on Human Peripheral Blood Dendritic Cells in Children [J].
Vasudev, Monica ;
Cheung, Dorothy S. ;
Pincsak, Hannah ;
Li, Shun-Hwa ;
Yan, Ke ;
Simpson, Pippa ;
Dasu, Trivikram ;
Grayson, Mitchell H. .
PLOS ONE, 2012, 7 (02)
[9]   Late Breaking Abstract - SHAMAL: reduction of maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab: a randomised phase 4 study [J].
Jackson, David J. ;
Heaney, Liam G. ;
Humbert, Marc ;
Kent, Brian D. ;
Hiljemark, Lina ;
Olinger, Lynda ;
Cohen, David ;
Menzies-Gow, Andrew ;
Korn, Stephanie .
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[10]   LATE-BREAKING ABSTRACT: Benralizumab provides significant improvements for patients with severe, uncontrolled asthma: SIROCCO Phase III results [J].
Bleecker, Eugene ;
FitzGerald, J. Mark ;
Chanez, Pascal ;
Papi, Alberto ;
Weinstein, Steve ;
Barker, Peter ;
Sproule, Stephanie ;
Gilmartin, Geoffrey ;
Aurivillius, Magnus ;
Werkstrom, Viktoria ;
Goldman, Mitchell .
EUROPEAN RESPIRATORY JOURNAL, 2016, 48